GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Gross Margin %

Elixxer (Elixxer) Gross Margin % : 0.00% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Elixxer's Gross Profit for the three months ended in Sep. 2023 was $0.00 Mil. Elixxer's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Elixxer's Gross Margin % for the quarter that ended in Sep. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Elixxer's Gross Margin % or its related term are showing as below:


ELIXF's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 47
* Ranked among companies with meaningful Gross Margin % only.

Elixxer had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Elixxer was 0.00% per year.


Elixxer Gross Margin % Historical Data

The historical data trend for Elixxer's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Gross Margin % Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Elixxer's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Elixxer's Gross Margin % falls into.



Elixxer Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Elixxer's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0.1 / 0.06
=(Revenue - Cost of Goods Sold) / Revenue
=(0.06 - 0) / 0.06
=N/A %

Elixxer's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Elixxer  (OTCPK:ELIXF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Elixxer had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Elixxer Gross Margin % Related Terms

Thank you for viewing the detailed overview of Elixxer's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (Elixxer) Business Description

Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (Elixxer) Headlines

From GuruFocus

Elixxer Ltd. Provides Corporate Update

By Marketwired Marketwired 02-26-2021

Little Green Pharma Holding exceeds $15M in value for Elixxer

By Marketwired Marketwired 12-01-2020

Elixxer Ltd. Provides Update on Proposed Private Placement

By Marketwired Marketwired 10-09-2020

Elixxer Ltd. Announces Revised Debt Settlement Transactions

By Marketwired Marketwired 03-02-2021

Elixxer Ltd. Closes $4 Million Secured Loan

By GlobeNewswire GlobeNewswire 10-07-2020